Related Blog Posts
Cancer trial drug hope for asthma
16 hours ago ago from Asthma News
A drug being tested to treat cancer could also help patients suffering from asthma, according to Edinburgh researchers. (Source: BBC News | Health | UK Edition)
Related contentNovartis’ Cancer Plan
21 hours ago ago from Drugsinus's Blog
Daniel Vasella Novartis rose to prominence thanks to the success of the blockbuster leukemia drug Gleevec. Now comes the hard part: finding an encore. Gleevec reaps sales of $3.5 billion a year and is still growing at double-digit rates. But its patent expires in 2015 and Novartis ( NVS news people ) cannot depend on it forever. Chief Executive Daniel Vasella hopes six newer cancer drugs two already on the market and four more in ...
Related contentNew Platinum Compound Potentially More Effective At Destroying Cancer Tumors
22 hours ago ago from The Cancer Foundation For The World - Cancer Sucks...We Can Make A Difference...The Answer For Cancer
Researchers in the US have developed and tested a new platinum compound that appears to be more effective at destroying cancer tumors than cisplatin, a commonly used FDA-approved drug that is administered by itself or with other drugs to treat mostly advanced bladder, ovarian, testicular and other cancers Read Full Article
Related contentImmune-boosting Drugs Could Enhance Cancer Treatment
22 hours ago ago from The Cancer Foundation For The World - Cancer Sucks...We Can Make A Difference...The Answer For Cancer
Stimulating the body's own immune system to fight cancer offers new treatment opportunities for patients and scientists have made the first step towards finding some existing cancer drugs that could help Read Full Article
Related contentDrug promising in immune system therapy
21 hours ago ago from Private Equity Fund LLC
Dana-Farber Cancer Institute researchers conducted the trial that was designed to determine if the drug bortezomib (Velcadea) could improve immune system recovery in patients receiving stem cell transplants from unrelated, partially matched donors. Advertisement: read more Social Bookmarking
Related contentRelated News
Cancer guidelines anger survivors | detnews.com | The Detroit News
6 hours ago ago from Detroit News
Archive: Thu | Fri | Sat | Sun | Mon | Tue | Wed | Today Last Updated: December 10. 2009 1:00AM Cancer guidelines anger survivors Advocates slam proposals for later, fewer screenings Kim Kozlowski / The Detroit News After a decade of breast ...
Related contentImmunogen reports positive breast cancer drug data
14 hours ago ago from Good News Now
NEW YORK -Immunogen Inc. said Wednesday its developing cancer treatment T-DM1 prompted a 32.7 percent response rate in a midstage study on breast cancer patients, pushing shares higher. The stock jumped 72 cents, or 8.8 percent, to close at $8.89, as investors viewed the results as positive for the drug candidate's regulatory prospects. The company will present the clinical data at the 32nd Annual San Antonio Breast Cancer Symposium on ...
Related contentNCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
19 hours ago ago from FanHouse
NCCN updates the NCCN Guidelines for Non-Small Cell Lung Cancer to include guidance on maintenance therapy, several new therapeutic recommendations for specific patients with Non-Small Cell Lung Cancer, and a revised staging system. FORT WASHINGTON, Pa., Dec. 9 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) to incorporate a new section ...
Related contentBeer Ingredient Eyed in Prostate Cancer Prevention
1 day ago ago from Forbes.com
WEDNESDAY, Dec. 9 (HealthDay News) -- An ingredient of beer may someday help ward off prostate cancer, new animal experiments suggest. The compound in question, xanthohumol, is found in hops -- the bitter flavoring agent in beer -- and is known to block the male hormone testosterone, which plays a role in the development of prostate cancer. We hope that one day we can demonstrate that xanthohumol prevents prostate cancer development, ...
Related contentMedifocus, Inc. Begins Trading on the Over The Counter (OTC)
21 hours ago ago from FanHouse
Medifocus, Inc. (TSXV:MFS) (OTC: MDFZE.PK) a biotechnology company focused on the commercialization of a proprietary and patented microwave focused heat system for the treatment of breast cancer is pleased to announce that the Company had begun trading its common stock on the OTC Pink Sheets market on Dec. 7, 2009. On June 9, 2009 Medifocus announced that Health Canada had granted full ITA approval to allow the initiation of Medifocus’ ...
Related contentRelated Videos
Nothing to see... move along.
